|
1
|
Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia.
|
Leukemia
|
2005
|
0.98
|
|
2
|
Activated T lymphocytes in pre-eclampsia.
|
Am J Reprod Immunol
|
2007
|
0.93
|
|
3
|
Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+ T cells as well as CD4+CD25+FoxP3+ regulatory T cells toward an antileukemia response.
|
Leukemia
|
2008
|
0.91
|
|
4
|
CD1c(+) immature myeloid dendritic cells are predominant in cord blood of healthy neonates.
|
Immunol Lett
|
2004
|
0.86
|
|
5
|
Enhanced phenotypic and functional maturation of monocyte-derived dendritic cells from patients with active Crohn's disease and ulcerative colitis.
|
J Physiol Pharmacol
|
2010
|
0.81
|
|
6
|
Surgery decreases number of cells secreting cytotoxic mediators and increases secretion of interleukin 10 in patients with lung cancer.
|
Eur J Surg Oncol
|
2013
|
0.79
|
|
7
|
Blood myeloid and lymphoid dendritic cells are stable during the menstrual cycle but deficient during mid-gestation.
|
J Reprod Immunol
|
2003
|
0.78
|
|
8
|
Myeloid and lymphoid dendritic cells in normal pregnancy and pre-eclampsia.
|
Clin Exp Immunol
|
2003
|
0.78
|